Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Parallel Controlled Study Evaluating the Safety and Efficacy of Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

NCT05785949 is registered in ClinicalTrials.gov with Geistlich Pharma AG as lead sponsor.

NCT NCT05785949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05785949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Parallel Controlled Study Evaluating the Safety and Efficacy of Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair
Lead sponsor
Geistlich Pharma AG
Phase
Not applicable
Overall status
Terminated
Start date
March 10, 2023
Completion date
January 31, 2026
Enrollment
75 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage defects